Related by context. All words. (Click for frequent words.) 73 Marketing Authorisation Application 72 Marketing Authorization Application 71 Raptiva R 70 SYCREST 70 Adenuric R 69 Certican 69 Sebivo 69 Tostrex 69 SEBIVO 68 GTC recombinant human 68 Somatuline R Autogel R 68 Centralized Procedure 68 Raptiva ® 67 YONDELIS 67 acyclovir Lauriad R 67 Marketing Authorisation 67 Oracea ® 67 JOULFERON 67 balsalazide tablet 67 Marketing Authorization Application MAA 66 Marketing Authorization 66 Biological License Application 66 Nivestim 66 Sanvar R 66 Increlex R 66 Biologics License Application 66 REBETOL combination therapy 66 Mutual Recognition Procedure 66 Ciclesonide 66 Alvesco ® 66 CONBRIZA 66 FIRAZYR 66 sorafenib tablets 66 Application MAA 65 ORENCIA R 65 Receives Marketing Authorization 65 FDA Approvable Letter 65 Biologic License Application BLA 65 Basilea Toctino R 65 Cellegesic 65 Alitretinoin 65 Decentralized Procedure DCP 65 sNDAs 65 liver resection surgeries 65 Orphan Drug Status 65 Loramyc R 65 Angiox ® 65 Marketing Authorisation Application MAA 65 hoFH 65 Marketing Authorizations 65 Decentralized Procedure 65 orphan designation 65 Toctino R 65 European Medicines Evaluation 65 MAA submission 65 Tigecycline 65 rasagiline tablets 65 Yondelis ® 65 Keppra ® XR 65 Plenaxis R 64 Trobalt 64 Files Investigational 64 TEMODAL 64 BENLYSTA 64 THELIN 64 Alvesco R 64 STELARA TM 64 RELISTOR ® 64 #D#C# 64 FOLOTYN ® 64 Oracea TM 64 Rhucin ® 64 OMP designation 64 prasterone 64 Tracleer r 64 UPLYSO 64 BRILINTA 64 Linjeta TM 64 Firazyr ® 64 Expedited Review 64 Rhucin R 64 Lumiracoxib 64 Drug Submission 64 GTC recombinant form 64 Receives Positive Opinion 64 Methylnaltrexone 64 methylnaltrexone bromide 64 Somatuline R Depot 64 GRAS notification 64 MOVIPREP R 64 miconazole MBT 64 Medicinal Products EMEA 64 CHMP recommendation 64 www.soliris.net 64 Zenpep 64 Civacir 64 Focetria 64 Orphan Drug status 63 RoACTEMRA 63 Japanese Encephalitis vaccine 63 Xyrem ® 63 Icatibant 63 Evoltra ® 63 YONDELIS R 63 Product Characteristics 63 Cimzia ® 63 Peginterferon alfa 2b 63 Rectogesic 63 IV acetaminophen 63 Wafer polifeprosan 63 Reclast Aclasta 63 Eloxatin ® 63 FDA Accepts 63 Tracleer R 63 rolling Biologics License 63 BLA filing 63 Gleevec Glivec 63 Movectro 63 Dacogen injection 63 efalizumab 63 BENLYSTA ® 63 Romiplostim 63 TORISEL TM 63 casopitant 63 Cloderm ® Cream 63 Ganciclovir 63 Valtropin 63 ORTHOVISC mini 63 Allovectin 7 r 63 CELVAPAN H#N# 63 Nabi HB Intravenous 63 Prestara TM 63 oral salmon calcitonin 63 Afinitor everolimus 63 Lubiprostone 63 TYZEKA 63 severe hypercholesterolemia 63 Humenza 63 novel emulsion formulation 63 CERVARIX R 63 Emezine 63 Pivotal Phase III 63 TRISENOX 63 capsule formulation 63 Biologic License Application 63 Fludara ® 63 NOXAFIL 63 ROTATEQ 63 histamine dihydrochloride 63 supplemental Biologics License Application 63 Nexavar ® 63 Announces Tentative Approval 63 vancomycin hydrochloride 63 Multiferon ® 63 Joulferon 63 Loramyc ® 63 rheumatoid arthritis psoriatic arthritis 63 MAAs 63 Orphan Drug designations 63 EGRIFTA TM 63 oxymorphone ER 63 Recombinant Human 63 acyclovir Lauriad ® 62 Teysuno 62 Kit CD# positive 62 ARIXTRA R 62 Clinical Trial Application 62 sublingual tablets 62 XIAFLEX TM 62 Clevudine 62 ICH guidelines 62 Dalbavancin 62 Toctino ® 62 Biologics License Applications 62 Hexvix ® 62 FACTIVE tablets 62 SUTENT ® 62 Thalidomide Pharmion 62 k Premarket Notification 62 Visian Toric ICL 62 Golimumab 62 ATRIPLA TM 62 Dementia Related Psychosis 62 docetaxel Taxotere ® 62 Accelerated Approval 62 intravenous acetaminophen 62 Hsp# Inhibitor 62 Retacrit 62 LEUKINE 62 Positive Opinion 62 Initiates Enrollment 62 Vitaros 62 EDQM 62 Market Authorization Application 62 Fast Track Status 62 Sycrest 62 Esbriet pirfenidone 62 Biologics License Application BLA 62 Friedreich Ataxia FRDA 62 Soliris TM eculizumab 62 BARACLUDE R 62 Serdolect ® 62 Dupuytren Contracture 62 bazedoxifene 62 Afatinib 62 Dyloject TM 62 ATryn ® GTC recombinant 62 Advagraf 62 Multiferon R 62 Voraxaze ™ 62 Modrenal R 62 DOXIL R 62 ONGLYZA ™ 62 PROVIGIL 62 Botox Botox Cosmetic 62 aripiprazole Abilify 62 CD# CEA 62 TransVax TM 62 CHMP opinion 62 rThrombin 62 RECOTHROM R 62 Ruconest 62 oropharyngeal candidiasis 62 buccal spray 62 BioDelivery Sciences Announces 62 SAFLUTAN 62 Nabi HB R 62 phase III isavuconazole 62 Mimpara 62 Approvable letter 62 MAGE A3 ASCI 62 receptor tyrosine kinase inhibitor 62 Velaglucerase Alfa 62 Pirfenidone 62 MYLOTARG 62 Alinia 62 AZILECT ® 62 HepaGam B 62 Orphan Status 62 Clofarabine 62 Aloxi ® 62 Zavesca r 62 ULTRASE 62 Orphan Drug designation 62 2 inhibitor CYT# 62 Noxafil 62 SNT MC# 62 Somatuline Autogel 62 Progenta TM 62 MCSP respectively 62 PROSTASCINT R 62 R sorafenib tablets 62 PrevOnco 62 Allovectin 7 ® 62 Calcium Acetate 62 highly purified pasteurized 61 XL# anticancer compounds 61 vapreotide acetate 61 BYETTA ® 61 thetreatment 61 TRISENOX ® 61 approvable letters 61 Aloxi R 61 Immune Globulin Human 61 Triage Stroke Panel 61 Aviptadil 61 TELINTRA 61 Loramyc ™ 61 Glybera R 61 novel VDA molecule 61 candidates Dyloject TM 61 including eniluracil ADH 61 DIFICID ™ 61 Receives Orphan Drug Designation 61 pioglitazone HCl 61 HepaGam B TM 61 Liprotamase 61 ZOSTAVAX 61 Approvable 61 Nimotuzumab 61 Granulocyte Colony Stimulating Factor 61 CAMPATH R 61 Increlex TM 61 VISICOL R 61 Targretin capsules 61 Ceflatonin 61 SAR# [004] 61 Loramyc 61 Febuxostat 61 gastrointestinal disorders ATI 61 AERIUS 61 ARCOXIA 61 PREVU * POC 61 cMET 61 EGRIFTA ™ 61 Vimpat ® lacosamide 61 biostatistical analysis 61 Voraxaze 61 ezogabine 61 Mycophenolate Mofetil 61 Thelin TM 61 human antithrombin 61 COMFORT II 61 Topical Gel 61 Irinotecan Hydrochloride Injection 61 Marketing Authorisations 61 Evoltra R 61 Veregen TM 61 ospemifene 61 Tibotec BVBA 61 Phase III Clinical Trial 61 Tredaptive 61 markets HP Acthar 61 GATTEX ® 61 SmPC 61 Levetiracetam Tablets 61 Zebinix R 61 Japanese Encephalitis Vaccine 61 injectable formulations 61 Esbriet ® 61 Orapred ODT 61 Aclasta Reclast 61 Thelin tm 61 PrandiMet 61 eCTD format 61 IMiDs 61 Neupro R 61 fusion enhancers 61 BEMA ® 61 REMINYL ® 61 Sestamibi 61 Rasilez HCT 61 ACOMPLIA R 61 Multaq dronedarone 61 INSPIRE Trial Phase III 61 ® daptomycin 61 CORTOSS Bone Augmentation Material 61 alvimopan 61 Allovectin 7 R 61 Submits Supplemental 61 Zevtera ™ 61 Anidulafungin 61 TYGACIL 61 Oncoscience AG 61 Zavesca ® 61 subsidiaries visit http:/www.apricusbio.com 61 HepeX B TM 61 Tasigna nilotinib 61 desvenlafaxine 61 BLA submission 61 Tarceva TM 61 Neupro ® 61 Crofelemer budesonide foam 61 Mimpara R 61 Fast Track designations 61 GLASSIA 61 MEZAVANT 61 Psoriasis Drug 61 supplemental biologics 61 ® bortezomib 61 prokinetic agent 61 oral methylnaltrexone 61 CAELYX 61 HFA MDI 61 Levoleucovorin 61 WHO prequalification 61 Glatiramer Acetate 61 Aflunov 61 NDA Submission 61 FACTIVE R gemifloxacin 61 Periostat R 61 Kamada AAT 61 Deferiprone 61 TORISEL 61 Metformin GR 61 Syndrome LEMS 61 dihydrochloride Tablets 61 Vidaza R 61 HCl capsules 61 Phase III Clinical Trials 61 cUTI 61 Kristalose ® lactulose 61 Complete Response 61 POSIDUR TM 61 LEVADEX ™ 61 PREVENAR 61 silodosin 61 Epo zeta 61 FRAGMIN 61 ruxolitinib 61 ZEGERID Capsules 61 ALN HPN 61 lexidronam injection 61 Xolegel 61 Supplemental Biologics License Application 61 recombinant interferon 61 Fortigel 61 Extina 61 ATryn ® 61 Embosphere R 61 Taiho Pharmaceutical 61 Entereg R 61 LUNESTA ® 60 Certolizumab pegol 60 QUADRAMET R 60 Rebif ® 60 GATTEX TM 60 Antitumor 60 application sNDA 60 prucalopride 60 miconazole Lauriad ® 60 Glargine 60 Preotact 60 Pazopanib 60 Mycamine 60 fluoroquinolone antibiotic 60 gastrointestinal disorders characterized 60 ATPace TM 60 Submits NDA 60 LibiGel ® 60 ZADAXIN ® 60 AzaSite Plus 60 ANDAs pending approval 60 myelodysplastic myeloproliferative diseases 60 PREOS R 60 Lenocta 60 novel oral anticoagulant 60 pantoprazole sodium 60 TYKERB 60 Firdapse 60 prGCD 60 Roche Xeloda 60 GERD migraine headaches 60 REMICADE ® 60 VIVITROL ® 60 PrandiMet TM 60 kidney urologic 60 ZALBIN 60 AMMONUL R 60 Tibotec Therapeutics division 60 Multiferon 60 ONCASPAR 60 Initiate Clinical Trial 60 Notified Bodies 60 Evoltra TM 60 Pirespa 60 Morphine Sulfate 60 Combidex 60 lorcaserin NDA 60 Initiates Clinical 60 Saforis 60 sitaxsentan sodium 60 Lovaza TM 60 PDUFA Date 60 ONGLYZA TM 60 Granted Orphan Drug 60 Glucomed 60 Pafuramidine 60 GW# [003] 60 Lambert Eaton Myasthenic 60 Arixtra ® 60 Amlodipine Besylate 60 refractory chronic lymphocytic 60 HepaSphere 60 FlutiformTM 60 Arzerra ofatumumab 60 gluteal injection 60 FOSAMAX PLUS D 60 Cefprozil 60 Pixuvri 60 FluLaval 60 Augment Injectable 60 PROVENGE ® 60 Campath ® 60 Soliris eculizumab 60 tenofovir disoproxil fumarate Viread 60 Proellex TM 60 MYCAMINE 60 APTIVUS ritonavir 60 single injection viscosupplement 60 Ranolazine 60 DASISION 60 Orathecin 60 acetonide FA 60 Proquin XR 60 Bonefos 60 sBLA 60 TRANSDUR ® 60 Solasia 60 Abstral ® 60 SEROQUEL R 60 Files IND 60 #mg #mg [002] 60 mesylate 60 FOR FURTHER INFORMATION ABOUT 60 Resubmission 60 human C1 inhibitor 60 Severe Sepsis 60 orphan medicinal product 60 TheraCIM 60 submitted Marketing Authorization 60 olanzapine LAI 60 R adalimumab 60 Tekamlo 60 Zorbtive TM 60 Augment ™ 60 Surfaxin LS 60 THALOMID 60 Vectibix panitumumab 60 prescription laxative 60 Premarket Approval PMA 60 Belimumab 60 COLAZAL R 60 Viviant 60 CE Marked 60 Completes Patient Enrollment 60 Metformin HCl 60 commercialize oritavancin 60 Imvamune 60 topical ophthalmic 60 Angiox 60 Premarket Approval Application 60 dirucotide MBP# 60 Personalized Immunotherapy 60 Junovan 60 everolimus tablets 60 methylnaltrexone bromide subcutaneous injection 60 Fortical R 60 Applications ANDA 60 XIAFLEX ™ 60 Submits Response 60 Actimmune ® 60 AMITIZA R 60 ALVESCO R 60 Vimpat R 60 Bendamustine 60 Mepact 60 REPLAGAL 60 HepeX B 60 ixabepilone 60 nonclinical studies 60 PREOS 60 Cimzia ® certolizumab pegol 60 ocular formulation 60 SPRYCEL ® 60 Fondaparinux 60 romiplostim 60 Polyphenon ® E 60 Preotact R 60 amifampridine phosphate 60 Silodosin 60 MKC# MT 60 Zalbin 60 Kuvan R 60 HuMax TAC 60 FDA Complete Response 60 ZYBRESTAT fosbretabulin 60 indiplon capsules 60 OvaRex ® MAb 60 IMiDs ® compound 60 TREDAPTIVE 60 eprodisate Fibrillex TM 60 APTIMA HPV assay 60 lymphoid malignancies 60 BLAs 60 rhLF 60 LUVENIQ 60 PROMACTA 60 IMVAMUNE R 60 Xanafide 60 Kuvan sapropterin dihydrochloride 60 NUEDEXTA ™ 60 Afinitor ® 60 Serdolect 60 r hGH 60 Receives Orphan Drug 60 Dabigatran etexilate 60 BioNeutral antimicrobial formulations 60 Firazyr 60 G#DT 60 pediatric Crohn disease 60 Octreolin 60 pioglitazone hydrochloride 59 herpetic keratitis 59 clobazam 59 Tracleer ® bosentan 59 Thalomid ® 59 R bendamustine hydrochloride 59 intravenous formulations 59 adenosine injection 59 Dacogen decitabine 59 darbepoetin alfa Aranesp 59 diagnostic molecular imaging 59 Nexavar sorafenib 59 OMAPRO ™ 59 AstraZeneca Symbicort 59 Pivotal Clinical Trial 59 XIAPEX ® 59 Alferon N Injection 59 microtubule inhibitor 59 Aryplase 59 Aceon 59 Ixempra 59 Expanded Indication 59 Application BLA 59 Mylan Receives Approval 59 tubulin inhibitor 59 metoprolol succinate 59 Velcade bortezomib 59 Renvela ® 59 lucinactant 59 Accelerated Assessment 59 LibiGel NDA 59 PGL# 59 Fodosine 59 Release Capsules 59 SinuNase ™ 59 Methylphenidate Transdermal System 59 Arranon 59 DNAwithPap TM Test 59 sNDA submission 59 FUSILEV ® 59 nasal calcitonin product 59 Aphthasol R 59 SPRIX ® 59 RAPTIVA 59 Dynepo 59 UCB Keppra 59 tramiprosate Alzhemed TM 59 hypereosinophilic syndrome 59 Sumatriptan Succinate 59 Clolar ® 59 AZILECT R 59 commercializing Loramyc ® 59 Initiates Phase III 59 Tekturna HCT 59 OLEPTRO 59 Amlodipine Besylate Tablets 59 panitumumab Vectibix 59 RANK Ligand inhibitor 59 Tumor Response 59 DepoBupivacaine TM 59 Gonal f 59 TransVax ™ 59 PLAVIX ® 59 Tilidine 59 Immunosuppressant 59 PD LID 59 Prodarsan R 59 pancreatic enzyme replacement 59 pancrelipase 59 Soriatane 59 AMITIZA lubiprostone 59 Zingo TM 59 PORxin TM platforms 59 Neulasta ® 59 cardio renal 59 pregabalin Lyrica 59 GENERIC SILDENAFIL SOFT Generic 59 Biosimilar 59 selective modulator 59 Navelbine R 59 Panflu TM Sinovac 59 intranasal formulation 59 PDE inhibitors 59 RhuDex ® 59 oncological indications 59 Angiox R 59 MoxDuo IR 59 recombinant FVIII 59 Zemiva TM 59 taliglucerase alfa 59 Calcitonin 59 SUMAVEL 59 solifenacin succinate 59 AMITIZA ® 59 CNTO 59 Evoltra 59 Eribulin 59 Panzem R 59 CINTREDEKIN BESUDOTOX 59 Somatuline ® Autogel ® 59 Pertuzumab 59 Dermylex TM 59 GRALISE 59 HepaSphere Microspheres 59 Nebido 59 Full Prescribing Information 59 QNEXA ® 59 Glycopyrrolate 59 Indomethacin 59 NEBIDO 59 Swissmedic 59 NerPharMa 59 TRANSDUR ™ 59 tramiprosate ALZHEMED TM 59 ATryn R 59 Dermylex R 59 IL# PE#QQR 59 CIP TRAMADOL ER 59 FDA APPROVES 59 SinuNase TM 59 1mg tablets 59 Fabry Disease 59 Eraxis 59 HYVISC R 59 successfully commercialize Iluvien 59 TWYNSTA ® 59 ZEFTERA ™ 59 Azilect ® 59 Risperidone Oral Solution 59 severe gastroparesis 59 PROCRIT R 59 Tezampanel 59 IXIARO 59 Exherin TM 59 XIAFLEX ® 59 promote ceftobiprole 59 commercialize toremifene 59 Anturol TM 59 Betaferon R 59 R lenalidomide 59 Dapagliflozin 59 maleate 59 topical NSAID 59 Orphan Designation 59 CIMYM 59 epigenetic therapies 59 SEROQUEL XR 59 eltrombopag 59 Firdapse TM amifampridine phosphate 59 DepoDur 59 Kepivance 59 Tamiflu oseltamivir phosphate 59 thymosin alpha 1 59 Myfortic 59 ChimeriVax JE 59 Orphan Medicinal Product 59 adult chronic ITP 59 Telatinib 59 interferon gamma 1b 59 Plicera 59 Faropenem 59 Seasonal Influenza Vaccine 59 constipation OIC 59 IND Investigational New 59 Receives Approvable Letter 59 Cancidas 59 JAK2 Inhibitor 59 Catena ® 59 oxandrolone USP 59 diabetic peripheral neuropathic pain 59 Phase IIIb clinical 59 Optaflu 59 eprodisate KIACTA TM 59 sunitinib Sutent 59 Copegus R 59 Orphan designation 59 Telavancin 59 FLUPAN 59 NDA resubmission 59 Bayer Onyx 59 StaphVAX R 59 NOVARTIS 59 telaprevir VX 59 Neuromodulation System 59 Pentacel vaccine 59 Cimzia certolizumab pegol 59 SUBOXONE 59 FDA approvable letter 59 ELIQUIS 59 Premarket Approval 59 Synvisc ONE 59 BUPHENYL 59 Scientific Advice 59 Mirapexin 59 PROMUS TM 59 hereditary deficiency 59 eribulin mesylate 59 Neulasta R 59 Ambrisentan 59 Firdapse ™ amifampridine phosphate 59 DRAXIMAGE 59 oral dual endothelin 59 Ketotransdel 59 Cipralex ® 59 Meets Primary Endpoint 59 Plenaxis TM 59 Bioral ® 59 SIMPONI TM 59 R bivalirudin 59 INVEGA ® 59 Tamibarotene 59 octreotide acetate 59 Amitiza ® 59 Xcytrin R 59 afamelanotide 59 human lactoferrin 59 Vascular Wrap TM 59 trabectedin 59 Serostim ® 59 Ixiaro 59 cinacalcet HCl 59 Sutent sunitinib 59 velaglucerase alfa 59 Gamunex C 59 biogeneric 58 FRDA 58 Product Monograph 58 Analgesics 58 acetylgalactosamine 6 58 Qutenza TM 58 Intravenous Hepatitis B 58 Release Tablets 58 CIMZIA r 58 ABILIFY R 58 OSMOPREP 58 #mg Tablets [002] 58 Investigational Compound 58 Stimulon adjuvant 58 Kuvan TM sapropterin 58 OFIRMEV 58 levocetirizine 58 Anticalin ® 58 Dermylex 58 ZEFTERA TM Zevtera TM 58 SANVAR 58 oncolytic virus therapies 58 LPM TM 58 Ranexa R 58 XIAPEX 58 VivaGel ™ 58 Nasdaq ONXX today 58 Aztreonam Lysine 58 RIGScan CR 58 corticotropin injection 58 Urocidin TM 58 Bazedoxifene 58 Budesonide foam crofelemer 58 Decapeptyl R 58 INDs 58 vismodegib 58 Sodium Injection 58 Darunavir 58 Linjeta ™ 58 PIX# trial 58 Panzem R NCD 58 LIVALO 58 breast cancer pill Tykerb 58 ATRIPLA 58 Oral Calcitonin 58 rufinamide 58 Diabetic Macular Edema 58 SIMPONI ® 58 ZOLINZA 58 memantine HCl 58 Ecallantide 58 Generic Version 58 albinterferon alfa 2b 58 MK #B 58 REBETOL combination 58 Pemetrexed 58 Edurant 58 Genzyme Myozyme 58 PDX pralatrexate 58 miRview meso 58 fluvoxamine maleate 58 Teikoku Pharma USA 58 Hepatocellular Carcinoma 58 #mg dosage strength 58 Tekturna Rasilez 58 LHRH antagonist 58 Warfarin Coumadin 58 Xelox 58 MGN# 58 Roflumilast 58 AAG geldanamycin analog 58 Pivotal Study 58 Taxotere ® 58 Ilaris 58 Cariprazine 58 topical diclofenac 58 Tenofovir Disoproxil Fumarate 58 psoriasis rheumatoid arthritis 58 ANDA Filing 58 induced macular edema 58 Torisel 58 ENLIGHT 58 Nanobody R 58 5mg #mg #mg 58 Synerx 58 PREVU x LT 58 Ruconest ™ 58 ISTODAX 58 DYSPORT 58 diarrhea predominant irritable 58 sarcoma melanoma 58 Berinert 58 buccal tablets 58 neratinib 58 refractory acute promyelocytic 58 multicenter Phase III 58 Diamyd r 58 Desvenlafaxine 58 NESINA 58 Entereg TM 58 oral rivaroxaban 58 relapsing remitting MS RRMS 58 Nutra Pharma wholly owned 58 Combination REOLYSIN R 58 adalimumab Humira 58 ZEVALIN ® 58 alefacept 58 torezolid phosphate 58 submitted Marketing Authorisation 58 David W. Gryska 58 VIAject R 58 Exforge HCT 58 Ocrelizumab 58 Cladribine Tablets 58 faropenem 58 Tesamorelin 58 Telbivudine 58 WinRho SDF 58 Sonolith i move 58 Master File DMF 58 riociguat 58 CRMD# 58 Ticagrelor 58 Ramelteon 58 quinolone antibiotic 58 RECOTHROM ® 58 EGFR HER2 58 BUPHENYL R 58 Patient Enrolment 58 BEXXAR 58 Hycamtin 58 Telzir 58 ZEFTERA TM 58 Elan NanoCrystal 58 gepirone ER 58 anti inflammatory NSAID 58 Cintredekin besudotox 58 include Alferon N 58 unique alkylating agent 58 Flutiform TM 58 Aptivus 58 JAK Inhibitor 58 pain palliation 58 Zemiva ™ 58 PrevOnco ™ 58 Ceplene TM 58 PROCRIT ® 58 IPM Wound Gel 58 Zenvia Phase III 58 Biologics Licensing 58 Insegia 58 Ofatumumab 58 GEM #S 58 DUROLANE 58 Erythropoiesis Stimulating Agents ESAs 58 recombinant biopharmaceutical 58 BEMA Fentanyl 58 Rotarix R 58 Octreotide 58 mesylate tablets 58 IBS C 58 albiglutide 58 Recommends Approval 58 painful diabetic neuropathy 58 CTAP# Capsules 58 Auxilium Pharma 58 Onco TCS 58 telavancin NDA 58 Cerashield 58 ITAX 58 MERREM 58 diabetic neuropathic pain 58 ORENCIA ® 58 Forsteo 58 DC Bead 58 Ustekinumab 58 mitogen activated ERK kinase 58 ionotropic glutamate receptor antagonists 58 known teratogen substance 58 UCB Cimzia 58 Aplenzin 58 ADDERALL XR R 58 BrachySil TM 58 Roche PEGASYS R 58 orphan medicinal 58 Luveris 58 huC# DM4 58 Opterone R 58 Paragraph IV 58 tolperisone 58 EpiCeram 58 Omacor ® 58 Ceftobiprole